TR
EN
A Toxic Threat: Determinants of Symptom Severity in Patients Under Intensive Care Due to Exposure to Aluminum Phosphide
Abstract
Aim: This study aims to identify the factors determining the severity of poisoning resulting from respiratory exposure to Aluminum Phosphide (AlP), commonly used as a rodenticide against pests in households in low socio-economic regions.
Materials and Methods: This is a single-center, retrospective observational study that reviewed the data of patients admitted to the emergency department due to AlP exposure and subsequently accepted into the toxicology intensive care unit between 2023 and 2024. The study utilized patients’ demographic characteristics, mode and duration of exposure, clinical findings, and outcomes. Student’s t-test was used for binary group comparisons, and one-way Analysis of Variance (ANOVA) was employed for comparisons among more than two groups. Continuous data not conforming to normal distribution were presented as median (interquartile range) and analyzed using the Mann-Whitney U test for two-group comparisons and the Kruskal-Wallis test for multiple-group comparisons. A p-value of <0.05 was considered statistically significant in all analyses.
Results: The median age of the 11 patients included in the study was 60 years (range 22–85). Of these, 64% were male (7 males, 4 females), and 36% were female. The relationship between Glasgow Coma Scale (GCS) and symptom severity was analyzed using the Kruskal-Wallis test and found to be significant (p = 0.027). Similarly, the relationship between lactate levels and symptom severity was significant (p = 0.009). Patients with lower GCS values exhibited higher lactate levels; for instance, all patients with GCS ≤ 8 had lactate levels >4 mmol/L. A strong negative correlation was observed between GCS and lactate levels (Spearman’s ρ ≈ –0.82, p < 0.01). The relationship between gender and lactate levels was analyzed using the Mann-Whitney U test, revealing significantly higher lactate levels in females (p = 0.015).
Conclusion: Advanced age, low GCS, high lactate levels, and female gender appear to necessitate more intensive monitoring and treatment in AlP poisonings. These findings may facilitate risk stratification.
Keywords
Supporting Institution
NONE
Project Number
NONE
Ethical Statement
This study received approval from the Local Ethics Committee of Konya City Hospital (Date: May 8, 2025; Protocol No: 09-51)
References
- Gurjar M, Baronia AK, Azim A, Sharma K. Managing aluminum phosphide poisonings. J Emerg Trauma Shock. 2011;4(3):378-384. doi:10.4103/0974-2700.83869
- Hakimoğlu S, Dikey İ, Sarı A, Kekeç L, Tuzcu K, Karcıoğlu M. Kardiyak arrestle sonuçlanan alüminyum fosfid zehirlenmesinin başarılı yönetimi. Turk J Anaesth Reanim. 2015;43(5):288-290. doi:10.5152/TJAR.2015.72152
- Siwach SB, Gupta A. The profile of acute poisonings in Haryana: Rohtak study. J Assoc Physicians India. 1995;43(12):756-759.
- Mehrpour O, Singh S. Rice tablet poisoning: a major concern in Iranian population. Hum Exp Toxicol. 2010;29(8):701-702. doi:10.1177/0960327110377529
- Hsu CH, Quistad GB, Casida JE. Phosphine-induced oxidative stress in Hepa 1c1c7 cells. Toxicol Sci. 1998;46(1):204-210. doi:10.1006/toxs.1998.2545
- Anger F, Paysant F, Brousse F, et al. Fatal aluminum phosphide poisoning. J Anal Toxicol. 2000;24(2):90-92. doi:10.1093/jat/24.2.90
- Chugh SN, Arora V, Sharma A, Chugh K. Free radical scavengers and lipid peroxidation in acute aluminium phosphide poisoning. Indian J Med Res. 1996;104:190-193.
- Solgi R, Abdollahi M. Proposing an antidote for poisonous phosphine in view of mitochondrial electrochemistry facts. J Med Hypotheses Ideas. 2012;6(1):32-34. doi:10.1016/j.jmhi.2011.09.001
Details
Primary Language
English
Subjects
Intensive Care
Journal Section
Research Article
Authors
Publication Date
September 1, 2025
Submission Date
August 17, 2025
Acceptance Date
August 23, 2025
Published in Issue
Year 2025 Volume: 7 Number: 2
APA
Vişneci, E. F., & Demirci, O. L. (2025). A Toxic Threat: Determinants of Symptom Severity in Patients Under Intensive Care Due to Exposure to Aluminum Phosphide. Eurasian Journal of Critical Care, 7(2), 13-18. https://doi.org/10.55994/ejcc.1767209
AMA
1.Vişneci EF, Demirci OL. A Toxic Threat: Determinants of Symptom Severity in Patients Under Intensive Care Due to Exposure to Aluminum Phosphide. Eurasian j Crit Care. 2025;7(2):13-18. doi:10.55994/ejcc.1767209
Chicago
Vişneci, Emin Fatih, and Osman Lütfi Demirci. 2025. “A Toxic Threat: Determinants of Symptom Severity in Patients Under Intensive Care Due to Exposure to Aluminum Phosphide”. Eurasian Journal of Critical Care 7 (2): 13-18. https://doi.org/10.55994/ejcc.1767209.
EndNote
Vişneci EF, Demirci OL (September 1, 2025) A Toxic Threat: Determinants of Symptom Severity in Patients Under Intensive Care Due to Exposure to Aluminum Phosphide. Eurasian Journal of Critical Care 7 2 13–18.
IEEE
[1]E. F. Vişneci and O. L. Demirci, “A Toxic Threat: Determinants of Symptom Severity in Patients Under Intensive Care Due to Exposure to Aluminum Phosphide”, Eurasian j Crit Care, vol. 7, no. 2, pp. 13–18, Sept. 2025, doi: 10.55994/ejcc.1767209.
ISNAD
Vişneci, Emin Fatih - Demirci, Osman Lütfi. “A Toxic Threat: Determinants of Symptom Severity in Patients Under Intensive Care Due to Exposure to Aluminum Phosphide”. Eurasian Journal of Critical Care 7/2 (September 1, 2025): 13-18. https://doi.org/10.55994/ejcc.1767209.
JAMA
1.Vişneci EF, Demirci OL. A Toxic Threat: Determinants of Symptom Severity in Patients Under Intensive Care Due to Exposure to Aluminum Phosphide. Eurasian j Crit Care. 2025;7:13–18.
MLA
Vişneci, Emin Fatih, and Osman Lütfi Demirci. “A Toxic Threat: Determinants of Symptom Severity in Patients Under Intensive Care Due to Exposure to Aluminum Phosphide”. Eurasian Journal of Critical Care, vol. 7, no. 2, Sept. 2025, pp. 13-18, doi:10.55994/ejcc.1767209.
Vancouver
1.Emin Fatih Vişneci, Osman Lütfi Demirci. A Toxic Threat: Determinants of Symptom Severity in Patients Under Intensive Care Due to Exposure to Aluminum Phosphide. Eurasian j Crit Care. 2025 Sep. 1;7(2):13-8. doi:10.55994/ejcc.1767209